Grants
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) (PAR-25-024)
Sponsor
National Institute of Neurological Disorders and Stroke
Due Date
Multiple due dates; see announcement.